Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderately Impaired Renal Function”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05431426
What this trial is testing

PK of CHF6001 in Subjects With Mild, Moderate and Severe Renal Impairment vs. Healthy Volunteers

Who this might be right for
Chronic Obstructive Pulmonary Disease
Chiesi Farmaceutici S.p.A. 44
Early research (Phase 1)Study completedNCT01512849
What this trial is testing

Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment

Who this might be right for
Type 2 Diabetes Mellitus
Tanabe Pharma Corporation 24
Early research (Phase 1)Study completedNCT03795389
What this trial is testing

Study to Assess PK, Safety and Tolerability in Patients With DM and CKD

Who this might be right for
Chronic Kidney DiseaseChronic Kidney Disease, Stage 3 (Moderate)Chronic Kidney Disease, Stage 4 (Severe)+1 more
DiaMedica Therapeutics Inc 33
Early research (Phase 1)Study completedNCT01569815
What this trial is testing

Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function

Who this might be right for
Mild and Moderate Renal Impairment
Novartis Pharmaceuticals 32
Large-scale testing (Phase 3)Study completedNCT00765830
What this trial is testing

Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)

Who this might be right for
Diabetes Mellitus, Type 2Renal Insufficiency
Novartis 349
Large-scale testing (Phase 3)Not Yet RecruitingNCT06606093
What this trial is testing

Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients

Who this might be right for
Type 2 Diabetic Nephropathy
Daewoong Pharmaceutical Co. LTD. 348
Not applicableStudy completedNCT02059811
What this trial is testing

Efficacy and Safety of the DASH Diet in Adults With Moderate Chronic Kidney Disease: Pilot Study

Who this might be right for
HypertensionChronic Kidney Disease
Duke University 42
Early research (Phase 1)Study completedNCT05117294
What this trial is testing

ASP0367 in People With Kidneys That do Not Work Well and in Healthy People

Who this might be right for
Renal ImpairmentHealthy Volunteers
Astellas Pharma Global Development, Inc. 13
Large-scale testing (Phase 3)Study completedNCT00614939
What this trial is testing

Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

Who this might be right for
Type 2 Diabetes
AstraZeneca 572
Testing effectiveness (Phase 2)Study completedNCT03115736
What this trial is testing

TAF for HIV-HBV With Renal Dysfunction

Who this might be right for
HIV and Hepatitis B Coinfection
Insel Gruppe AG, University Hospital Bern 24
Large-scale testing (Phase 3)Study completedNCT03998163
What this trial is testing

CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

Who this might be right for
Uremic Pruritus
Cara Therapeutics, Inc. 222
Large-scale testing (Phase 3)Study completedNCT00273871
What this trial is testing

Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients

Who this might be right for
Graft RejectionKidney FailureKidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 190
Testing effectiveness (Phase 2)Study completedNCT02678000
What this trial is testing

Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function

Who this might be right for
Chronic Kidney Disease (CKD)
Novartis Pharmaceuticals 84
Early research (Phase 1)WithdrawnNCT01407900
What this trial is testing

Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction

Who this might be right for
Heart FailureRenal Insufficiency
John A. Schirger
Early research (Phase 1)Study completedNCT05468749
What this trial is testing

Study to Assess the Effect of Renal Impairment on the Pharmacokinetics of CTP-543

Who this might be right for
Renal Impairment
Concert Pharmaceuticals 16
Early research (Phase 1)Study completedNCT03097016
What this trial is testing

Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Insufficiency
Celgene 48
Early research (Phase 1)Study completedNCT00938158
What this trial is testing

The Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 75
Early research (Phase 1)Study completedNCT01485900
What this trial is testing

Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment

Who this might be right for
Chronic Kidney Disease
Sanofi 20
Early research (Phase 1)Study completedNCT04476407
What this trial is testing

Pharmacokinetics of Benapenem in Subjects With Renal Impairment

Who this might be right for
Complicated Urinary Tract Infection; Cuti
Sihuan Pharmaceutical Holdings Group Ltd. 18
Testing effectiveness (Phase 2)Looking for participantsNCT06593392
What this trial is testing

Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus

Who this might be right for
PruritusChronic Kidney Diseases
Vifor Fresenius Medical Care Renal Pharma 18
Next Page